Retinal hypoxia after experimental subarachnoid hemorrhage.

Area of Science:

• Neuroscience
• Ophthalmology
• Pathology

Background:

• Subarachnoid hemorrhage (SAH) survivors frequently experience long-term neurological deficits.
• Pathological retinal changes following SAH have not been previously reported.

Purpose of the Study:

• To investigate the pathological alterations in the retina subsequent to experimental subarachnoid hemorrhage (SAH).
• To examine the role of the hypoxia-inducible factor-1α (HIF-1α)/vascular endothelial growth factor-A (VEGF-A) pathway in SAH-induced retinal changes.

Main Methods:

• An experimental SAH model was created in Sprague-Dawley rats by injecting autologous blood.
• Hematoxylin and eosin staining assessed retinal morphology.
• Immunofluorescence and immunohistochemistry detected retinal neovascularization (NVs) via CD31 labeling.
• Western blot analysis quantified the time-course expression of VEGF-A and HIF-1α.

Main Results:

• SAH induced a significant reduction in retinal ganglion cells (RGCs).
• Increased retinal neovascularization (NVs) was observed in the RGC layer post-SAH.
• VEGF-A levels peaked at 12 hours and 14 days after SAH.
• HIF-1α expression increased early, peaking at 12 hours post-SAH.

Conclusions:

• SAH triggers retinal hypoxia, causing RGC loss and neovascularization.
• The HIF-1α/VEGF-A pathway is activated in response to SAH-induced retinal hypoxia.
• These findings elucidate a novel pathological mechanism in the retina following SAH.